These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32327292)

  • 1. Optimal Medical Treatment vs. Invasive Approach in Patients with Significantly Obstructive Coronary Artery Disease and Ischemia.
    Carvajal-Juarez I; Espínola-Zavaleta N; Antonio-Villa NE; Keirns C; Alexanderson-Rosas E
    Arch Med Res; 2020 Jul; 51(5):413-418. PubMed ID: 32327292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
    Pursnani S; Korley F; Gopaul R; Kanade P; Chandra N; Shaw RE; Bangalore S
    Circ Cardiovasc Interv; 2012 Aug; 5(4):476-90. PubMed ID: 22872053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    Mancini GB; Farkouh ME; Brooks MM; Chaitman BR; Boden WE; Vlachos H; Hartigan PM; Siami FS; Sidhu MS; Bittner V; Frye R; Fuster V
    J Am Coll Cardiol; 2016 Sep; 68(10):985-95. PubMed ID: 27585501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Long-Term Mortality in Patients With Previous Coronary Artery Bypass Grafting Who Underwent Percutaneous Coronary Intervention With Versus Without Optimal Medical Therapy.
    Nakamura Y; Asaumi Y; Miyagi T; Nakai M; Nishimura K; Sugane H; Matama H; Kataoka Y; Miyamoto Y; Takeishi Y; Noguchi T; Yasuda S
    Am J Cardiol; 2018 Jul; 122(2):206-212. PubMed ID: 29747859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
    Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
    Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
    Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
    J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
    Shaw LJ; Weintraub WS; Maron DJ; Hartigan PM; Hachamovitch R; Min JK; Dada M; Mancini GB; Hayes SW; O'Rourke RA; Spertus JA; Kostuk W; Gosselin G; Chaitman BR; Knudtson M; Friedman J; Slomka P; Germano G; Bates ER; Teo KK; Boden WE; Berman DS
    Am Heart J; 2012 Aug; 164(2):243-50. PubMed ID: 22877811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
    Tandar A; Boden WE
    Curr Opin Cardiol; 2009 Nov; 24(6):591-5. PubMed ID: 19752728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
    Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L;
    Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The State of Percutaneous Intervention in Stable Coronary Artery Disease.
    Drescher C; Rao SV
    Curr Atheroscler Rep; 2020 Jul; 22(8):42. PubMed ID: 32671483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal medical therapy may be a better initial strategy in patients with chronic total occlusion of a single coronary artery.
    Hwang JW; Yang JH; Choi SH; Hwang JK; Jang WJ; Hahn JY; Song YB; Choi JH; Lee SH; Gwon HC
    Int J Cardiol; 2016 May; 210():56-62. PubMed ID: 26930638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.